What are the typical clinical presentation and recommended management for a quetiapine overdose?

Quetiapine Overdose: Clinical Presentation and Management

Quetiapine overdose primarily causes CNS depression (drowsiness to coma), tachycardia, and hypotension, with management focused on aggressive supportive care including early airway protection, cardiovascular monitoring, and activated charcoal if presenting within 1-2 hours of ingestion.

Clinical Presentation

Common Features (in order of frequency)

• CNS Depression: Drowsiness (76% of cases) progressing to coma (10%) 1, 2
• Tachycardia: Present in 56% of cases 2
• Hypotension: Occurs in 18% of cases, often refractory due to alpha-1 adrenergic blockade 1, 2
• Respiratory Depression: 5% of cases, requiring mechanical ventilation 2
• QTc Prolongation: Common but rarely progresses to torsades de pointes 1, 3

Dose-Related Severity Thresholds

Alert levels that predict severe toxicity 3:

• Ingested dose >3 grams: High risk for severe clinical course
• Peak serum concentration >2 mg/L: Increased risk for intubation, seizures, and cardiovascular complications
• Median toxic dose in case series: 10 grams 3

Less Common but Serious Complications

• Seizures: 2-4% of cases 2, 4
• Hypokalemia: Present in 50% of severe cases 4
• Hyperglycemia: Occurs in 25% of severe overdoses 4
• Anticholinergic delirium: Recognized in 40% of severe cases 4
• Aspiration pneumonia: Developed in 75% of intubated patients 4

Pharmacokinetic Considerations

The half-life is significantly prolonged to 16.5 hours in overdose (versus 6 hours therapeutically), with some cases showing biphasic absorption or secondary peaks 3, 4. This necessitates extended monitoring periods.

Management Algorithm

Immediate Stabilization (First 30 minutes)

1. Airway Assessment and Protection

   • Early intubation threshold: Consider for any patient with decreased level of consciousness, given rapid progression to coma and high aspiration risk 1, 5
   • Gastric lavage only if intubated and presenting within 1 hour 1
   • The risk of obtundation, seizures, or dystonic reactions creates aspiration risk with induced emesis 1

2. Cardiovascular Monitoring

   • Continuous ECG monitoring for arrhythmias, QTc prolongation 1
   • Establish IV access immediately
   • Baseline electrolytes (particularly potassium), glucose 4

3. Decontamination (if <1-2 hours post-ingestion)

   • Activated charcoal 50g (adult) with laxative if airway protected 1
   • Do NOT induce emesis due to aspiration risk 1

Specific Interventions

For Hypotension/Circulatory Collapse 1:

• IV fluids as first-line
• Sympathomimetic agents: Use norepinephrine or phenylephrine
• AVOID epinephrine and dopamine: Beta-stimulation worsens hypotension in the setting of quetiapine-induced alpha blockade 1

For Cardiac Arrhythmias 1:

• AVOID: Disopyramide, procainamide, and quinidine (additive QT-prolonging effects)
• AVOID: Bretylium (additive alpha-blocking properties causing problematic hypotension)
• Standard ACLS protocols otherwise

For Anticholinergic Delirium 4:

• Physostigmine: Consider in severe cases with good clinical response reported in 75% of cases 4

For Severe Extrapyramidal Symptoms 1:

• Anticholinergic medication (e.g., benztropine, diphenhydramine)

Critical Pitfalls to Avoid

1. Underestimating respiratory compromise: The progression from drowsiness to coma requiring intubation can be rapid—maintain low threshold for airway protection 5

2. Wrong vasopressor choice: Using epinephrine or dopamine will paradoxically worsen hypotension due to unopposed beta-stimulation in the presence of alpha-blockade 1

3. Premature discharge: The prolonged half-life (16.5 hours) and potential for biphasic absorption mandate extended observation of at least 24 hours for moderate-to-severe ingestions 3, 4

4. Missing complications: Monitor for hypokalemia, hyperglycemia, and aspiration pneumonia—these occur frequently and require specific management 4

5. Assuming benign course with lower doses: Even doses of 3-5 grams can cause severe toxicity requiring ICU admission 3

Monitoring Duration and Disposition

ICU Admission Criteria 5:

• Any patient requiring hospitalization should be admitted to ICU
• Minimum 24-hour observation for moderate-to-severe ingestions
• Continue monitoring until complete clinical recovery given prolonged half-life

Observation Parameters:

• Continuous cardiac monitoring
• Serial neurological assessments
• Electrolytes (especially potassium)
• Blood glucose
• Respiratory status

Outcome Expectations

Quetiapine overdose carries higher morbidity than other antipsychotics, with 2.6 times greater odds of death or major medical outcome compared to other antipsychotic overdoses 2. However, with aggressive supportive care, most patients recover fully within 2-3 days 1, 5. The three reported deaths in clinical trials all presented with the triad of coma, tachycardia, and respiratory depression requiring ventilatory support 1.

There is no specific antidote to quetiapine 1—management is entirely supportive, making early recognition and aggressive intervention critical for preventing mortality.